NR-565 Advanced Pharmacology Final Exam: (Latest
2026/2027 Update) Thyroid, Diabetes, Respiratory, GI, &
Complementary Therapies | Q&A | Grade A | 100% Correct
Verified Answers
Subject: Advanced Pharmacology – Thyroid disorders (methimazole, levothyroxine, radioactive iodine,
Graves disease); Type 1 & Type 2 diabetes (metformin, insulin glargine/detemir, pioglitazone,
sulfonylureas, SGLT-2 inhibitors, GLP-1 agonists, gemfibrozil interactions); Asthma/COPD (albuterol,
salmeterol, montelukast, inhaled/systemic glucocorticoids, anticholinergics, theophylline); GI disorders
(laxatives, colonoscopy prep, antiemetics, PUD, H. pylori, GERD, metoclopramide, alosetron,
lubiprostone, sucralfate, ondansetron); TB treatment (isoniazid, rifampin, pyrazinamide, ethambutol,
drug-resistant TB, HIV/TB); Complementary/Alternative Medicine (St. John's wort, saw palmetto,
DSHEA, NCCIH).
Source: NR-565 Final Exam Blueprint 2026/2027, ADA Standards, GINA Guidelines, IDSA/ATS TB
Guidelines, ACG Clinical Guidelines, NCCIH.
Format: Q&A Guide with Clinical Rationale | Verified Answers | Grade A Guaranteed
Radioactive iodine adverse effects?
Correct Answer: Destroys overactive thyroid cells – effectively reducing hormone levels (post-
treatment hypothyroidism in most patients).
1. Radioactive iodine (RAI) is absorbed by thyroid follicular cells, causing progressive destruction and
fibrosis. Most patients eventually become hypothyroid and require lifelong levothyroxine replacement.
2. Other adverse effects: transient neck pain/tenderness (radiation thyroiditis), sialadenitis (salivary gland
inflammation), dry mouth, altered taste. Contraindicated in pregnancy (teratogenic).
3. Monitor for hypothyroidism with TSH every 4-6 weeks for first 6 months, then every 6-12 months.
Methimazole indication and MOA
Correct Answer: Treats hyperthyroidism by inhibiting thyroid hormone synthesis. Blocks the
enzyme thyroid peroxidase (TPO), which is involved in the synthesis of thyroid hormones T3 & T4 –
effectively reducing levels in the body.
1. Methimazole is a thionamide; preferred over PTU except in first trimester pregnancy (PTU preferred
due to teratogenicity concerns). Blocks oxidation of iodide and iodination of tyrosine.
2. Onset: 4-8 weeks for euthyroid state. Duration of therapy: 12-18 months, then attempt remission (50%
relapse rate).
3. Adverse effects: agranulocytosis (sore throat, fever – report immediately); hepatotoxicity (cholestatic
pattern); rash, arthralgias.
, Levothyroxine (Synthroid) education and monitoring
Correct Answer: Take on empty stomach, 30-60 mins before breakfast. Do not take with
supplements (Mg, Ca, iron) – wait four hours. Monitor TSH levels 6-8 weeks after starting treatment.
1. Levothyroxine absorption is impaired by food, calcium, iron, magnesium, aluminum (antacids), and
soy. Consistent dosing and timing are critical; brand-to-generic switching requires caution (narrow
therapeutic index).
2. Monitoring: TSH every 6-8 weeks after initiation or dose change, then annually once stable. Goal TSH:
0.5-4.5 mIU/L (individualize).
3. Population considerations: elderly start low (25 mcg/day) to avoid atrial fibrillation. Pregnancy requires
increased dose (by 30-50%) and monthly TSH monitoring.
Pioglitazone contraindications
Correct Answer: Patients with severe heart failure (NYHA class III/IV) and history of bladder cancer.
1. Pioglitazone (TZD) causes fluid retention (weight gain, edema) and may precipitate or worsen heart
failure. Avoid in NYHA III/IV; caution in I/II. Monitor for dyspnea, edema, rapid weight gain.
2. Bladder cancer risk: meta-analyses show small increased risk with long-term use; avoid in patients
with active bladder cancer. Consider alternative agents if risk factors present.
3. Additional risks: osteoporosis/fractures (especially in women), ovulation in anovulatory premenopausal
women (counsel on contraception), and possibly macular edema.
Gemfibrozil (Lopid) drug interactions
Correct Answer: Displaces warfarin from plasma albumin → measure INR frequently → may need to
reduce warfarin dose. Increases risk of myopathy with statins (especially when combined with
lovastatin, simvastatin).
1. Gemfibrozil is a fibrate; it inhibits CYP2C8 and CYP2C9 and displaces warfarin from albumin. Monitor
INR closely (can increase 2-3 fold). Avoid gemfibrozil-statin combination (use fenofibrate if needed).
2. Indications: severe hypertriglyceridemia (>500 mg/dL) to prevent pancreatitis; also modest HDL
elevation.
3. Contraindications: severe hepatic or renal dysfunction, gallbladder disease (increases gallstones).
Insulin detemir (Levemir): dosing, duration, indications
Correct Answer: Indicated to provide a steady level of insulin throughout day and night (basal
glycemic control). Low doses 0.2 units/kg, higher doses 0.4 units/kg. Duration: up to 24 hours.
1. Insulin detemir is a long-acting basal insulin analog with a relatively flat profile. Duration: 12-24 hours
(duration shorter in children; may require BID dosing).
2. Dosing: once daily (evening) or BID (if duration <24 hours). Titrate by 2-4 units every 3 days based on
fasting glucose (goal 80-130 mg/dL).
3. Compare to glargine (Lantus): detemir has less weight gain but possibly higher hypoglycemia risk at
higher doses. Not for IV use.
2026/2027 Update) Thyroid, Diabetes, Respiratory, GI, &
Complementary Therapies | Q&A | Grade A | 100% Correct
Verified Answers
Subject: Advanced Pharmacology – Thyroid disorders (methimazole, levothyroxine, radioactive iodine,
Graves disease); Type 1 & Type 2 diabetes (metformin, insulin glargine/detemir, pioglitazone,
sulfonylureas, SGLT-2 inhibitors, GLP-1 agonists, gemfibrozil interactions); Asthma/COPD (albuterol,
salmeterol, montelukast, inhaled/systemic glucocorticoids, anticholinergics, theophylline); GI disorders
(laxatives, colonoscopy prep, antiemetics, PUD, H. pylori, GERD, metoclopramide, alosetron,
lubiprostone, sucralfate, ondansetron); TB treatment (isoniazid, rifampin, pyrazinamide, ethambutol,
drug-resistant TB, HIV/TB); Complementary/Alternative Medicine (St. John's wort, saw palmetto,
DSHEA, NCCIH).
Source: NR-565 Final Exam Blueprint 2026/2027, ADA Standards, GINA Guidelines, IDSA/ATS TB
Guidelines, ACG Clinical Guidelines, NCCIH.
Format: Q&A Guide with Clinical Rationale | Verified Answers | Grade A Guaranteed
Radioactive iodine adverse effects?
Correct Answer: Destroys overactive thyroid cells – effectively reducing hormone levels (post-
treatment hypothyroidism in most patients).
1. Radioactive iodine (RAI) is absorbed by thyroid follicular cells, causing progressive destruction and
fibrosis. Most patients eventually become hypothyroid and require lifelong levothyroxine replacement.
2. Other adverse effects: transient neck pain/tenderness (radiation thyroiditis), sialadenitis (salivary gland
inflammation), dry mouth, altered taste. Contraindicated in pregnancy (teratogenic).
3. Monitor for hypothyroidism with TSH every 4-6 weeks for first 6 months, then every 6-12 months.
Methimazole indication and MOA
Correct Answer: Treats hyperthyroidism by inhibiting thyroid hormone synthesis. Blocks the
enzyme thyroid peroxidase (TPO), which is involved in the synthesis of thyroid hormones T3 & T4 –
effectively reducing levels in the body.
1. Methimazole is a thionamide; preferred over PTU except in first trimester pregnancy (PTU preferred
due to teratogenicity concerns). Blocks oxidation of iodide and iodination of tyrosine.
2. Onset: 4-8 weeks for euthyroid state. Duration of therapy: 12-18 months, then attempt remission (50%
relapse rate).
3. Adverse effects: agranulocytosis (sore throat, fever – report immediately); hepatotoxicity (cholestatic
pattern); rash, arthralgias.
, Levothyroxine (Synthroid) education and monitoring
Correct Answer: Take on empty stomach, 30-60 mins before breakfast. Do not take with
supplements (Mg, Ca, iron) – wait four hours. Monitor TSH levels 6-8 weeks after starting treatment.
1. Levothyroxine absorption is impaired by food, calcium, iron, magnesium, aluminum (antacids), and
soy. Consistent dosing and timing are critical; brand-to-generic switching requires caution (narrow
therapeutic index).
2. Monitoring: TSH every 6-8 weeks after initiation or dose change, then annually once stable. Goal TSH:
0.5-4.5 mIU/L (individualize).
3. Population considerations: elderly start low (25 mcg/day) to avoid atrial fibrillation. Pregnancy requires
increased dose (by 30-50%) and monthly TSH monitoring.
Pioglitazone contraindications
Correct Answer: Patients with severe heart failure (NYHA class III/IV) and history of bladder cancer.
1. Pioglitazone (TZD) causes fluid retention (weight gain, edema) and may precipitate or worsen heart
failure. Avoid in NYHA III/IV; caution in I/II. Monitor for dyspnea, edema, rapid weight gain.
2. Bladder cancer risk: meta-analyses show small increased risk with long-term use; avoid in patients
with active bladder cancer. Consider alternative agents if risk factors present.
3. Additional risks: osteoporosis/fractures (especially in women), ovulation in anovulatory premenopausal
women (counsel on contraception), and possibly macular edema.
Gemfibrozil (Lopid) drug interactions
Correct Answer: Displaces warfarin from plasma albumin → measure INR frequently → may need to
reduce warfarin dose. Increases risk of myopathy with statins (especially when combined with
lovastatin, simvastatin).
1. Gemfibrozil is a fibrate; it inhibits CYP2C8 and CYP2C9 and displaces warfarin from albumin. Monitor
INR closely (can increase 2-3 fold). Avoid gemfibrozil-statin combination (use fenofibrate if needed).
2. Indications: severe hypertriglyceridemia (>500 mg/dL) to prevent pancreatitis; also modest HDL
elevation.
3. Contraindications: severe hepatic or renal dysfunction, gallbladder disease (increases gallstones).
Insulin detemir (Levemir): dosing, duration, indications
Correct Answer: Indicated to provide a steady level of insulin throughout day and night (basal
glycemic control). Low doses 0.2 units/kg, higher doses 0.4 units/kg. Duration: up to 24 hours.
1. Insulin detemir is a long-acting basal insulin analog with a relatively flat profile. Duration: 12-24 hours
(duration shorter in children; may require BID dosing).
2. Dosing: once daily (evening) or BID (if duration <24 hours). Titrate by 2-4 units every 3 days based on
fasting glucose (goal 80-130 mg/dL).
3. Compare to glargine (Lantus): detemir has less weight gain but possibly higher hypoglycemia risk at
higher doses. Not for IV use.
